Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-014003
Filing Date
2022-04-08
Accepted
2022-04-08 16:27:34
Documents
9
Period of Report
2022-04-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A _EGM alks-pre14a_20211231.htm PRE 14A 404523
2 GRAPHIC guqoxfkexpae000005.jpg GRAPHIC 1146
3 GRAPHIC guqoxfkexpae000002.jpg GRAPHIC 4902
4 GRAPHIC guqoxfkexpae000001.jpg GRAPHIC 4902
5 GRAPHIC guqoxfkexpae000006.jpg GRAPHIC 1084
6 GRAPHIC guqoxfkexpae000004.jpg GRAPHIC 1121
7 GRAPHIC guqoxfkexpae000008.jpg GRAPHIC 89389
8 GRAPHIC guqoxfkexpae000007.jpg GRAPHIC 128987
9 GRAPHIC guqoxfkexpae000003.jpg GRAPHIC 1170
  Complete submission text file 0001564590-22-014003.txt   727443
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35299 | Film No.: 22817343
SIC: 2834 Pharmaceutical Preparations